TCOT
IRD

Trust Company of Toledo’s Opus Genetics IRD Stock Holding History

Trust Company of Toledo’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,963
Closed -$30.4K – 782
2025
Q1 		$30.4K Hold
30,963
– – ﹤0.01% 235
2024
Q4 		$36.8K Hold
30,963
– – ﹤0.01% 234
2024
Q3 		$40.6K Hold
30,963
– – 0.01% 233
2024
Q2 		$47.4K Hold
30,963
– – 0.01% 229
2024
Q1 		$62.2K Hold
30,963
– – 0.01% 223
2023
Q4 		$93.2K Hold
30,963
– – 0.02% 214
2023
Q3 		$104K Sell
30,963
-1,436
-4% -$5.77K 0.02% 206
2023
Q2 		$141K Buy
32,399
+6,399
+25% +$30.4K 0.02% 195
2023
Q1 		$97.5K Buy
+26,000
New +$93.4K 0.02% 196

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Trust Company of Toledo's IRD Position: Q2 2025 in Review

Trust Company of Toledo sold out of Opus Genetics (IRD) in Q2 2025, closing a stake of 30,963 shares — an estimated $30.4K sold.

Trust Company of Toledo first reported a position in IRD in Q1 2023 and held it in 9 quarters. The position peaked at $141K in Q2 2023. 43 funds tracked by Wall St. Rank hold IRD as of Q2 2025.

  • Trust Company of Toledo reported no remaining Opus Genetics position as of Q2 2025 after selling out during the quarter.
  • Trust Company of Toledo sold 30,963 Opus Genetics shares in Q2 2025, an estimated $30.4K.
  • Trust Company of Toledo first reported a position in Opus Genetics in Q1 2023 and held it in 9 quarters.
  • Trust Company of Toledo's Opus Genetics position peaked at $141K in Q2 2023.
  • 43 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2025.

Based on Trust Company of Toledo's 13F filing for Q2 2025, filed 24 Jul 2025.